Prenatal diagnosis of Down's Syndrome using isolation of foetal cells from cervical mucous and peripheral blood during first trimester of pregnancy

Withdrawn

• Conditions: Pregnant women; Reproductive Health and Childbirth - Other reproductive health and childbirth disorders; Human Genetics and Inherited Disorders - Down's syndrome

• Registration Number: ACTRN12606000460505
• Lead Sponsor: Genetic Technologies Ltd

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2006-11-02
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Withdrawn
• Sex: Female
• Target Recruitment: 2000

Inclusion Criteria

Pregnant women presenting for Chorionic Villous Sampling.

Exclusion Criteria

Pregnant women not requiring an invasive test.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Sensitivity of the assay to detect Down Syndrome is assessed within 24 hours after the samples have been obtained.[24 months]

Secondary Outcome Measures

Name	Time	Method
Miscarriage Rate[24 months]